Joseph Rice
Director/Board Member at BANC OF CALIFORNIA, INC.
Net worth: 417 628 $ as of 2024-04-29
Joseph Rice active positions
Companies | Position | Start | End |
---|---|---|---|
BANC OF CALIFORNIA, INC. | Director/Board Member | 2023-05-10 | - |
Independent Dir/Board Member | 2023-05-10 | - | |
Nammi Therapeutics, Inc.
Nammi Therapeutics, Inc. BiotechnologyHealth Technology Nammi Therapeutics, Inc. specializes in prodrug design that allows for efficient and stable incorporation into nammisomes. The American company's technology maintains immune modulating agents in an inactive state until released by intracellular esterases, and provides IP and FTO. The private company was founded by David Stover. David Stover has been the CEO since incorporation. | Chief Operating Officer | 2021-12-31 | - |
The Painted Turtle Camp Foundation | Director/Board Member | - | - |
Music Center of | Director/Board Member | - | - |
Career history of Joseph Rice
Former positions of Joseph Rice
Companies | Position | Start | End |
---|---|---|---|
WELLS FARGO & COMPANY | Corporate Officer/Principal | 2009-12-31 | 2015-12-31 |
Training of Joseph Rice
University of California, Los Angeles | Undergraduate Degree |
University of California, Berkeley | Masters Business Admin |
Statistics
International
United States | 8 |
Operational
Director/Board Member | 3 |
Independent Dir/Board Member | 1 |
Chief Operating Officer | 1 |
Sectoral
Finance | 3 |
Consumer Services | 3 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
WELLS FARGO & COMPANY | Finance |
BANC OF CALIFORNIA, INC. | Finance |
Private companies | 3 |
---|---|
The Painted Turtle Camp Foundation | |
Music Center of | |
Nammi Therapeutics, Inc.
Nammi Therapeutics, Inc. BiotechnologyHealth Technology Nammi Therapeutics, Inc. specializes in prodrug design that allows for efficient and stable incorporation into nammisomes. The American company's technology maintains immune modulating agents in an inactive state until released by intracellular esterases, and provides IP and FTO. The private company was founded by David Stover. David Stover has been the CEO since incorporation. | Health Technology |
- Stock Market
- Insiders
- Joseph Rice
- Experience